![[Search]](/static/images/search.gif){kind=small}
![[A-Z Index]](/static/images/az.gif){kind=small}
![[Contact]](/static/images/contact.gif){kind=small}
![[University of Cambridge]](/static/images/identifier2.gif){kind=small}
![[Talks.cam]](/static/images/talkslogosmall.gif)
Dr Clifton E. Barry III, Tuberculosis Research Section, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD
Monday 09 January 2012, 17:00-18:00
Mechanisms matter: understanding and optimizing drugs for the treatment of tuberculosis
⚠️ Important: Joint Biological/Synthetic RIG Seminar
- 👤 Speaker: Dr Clifton E. Barry III, Tuberculosis Research Section, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD
- 📅 Date & Time: Monday 09 January 2012, 17:00 - 18:00
- 📍 Venue: Pfizer Lecture Theatre, Department of Chemistry
Questions? Contact
Catherine Jordan
Abstract
Abstract not available
Series This talk is part of the Biological Chemistry Research Interest Group series.
Included in Lists
- All Talks (aka the CURE list)
- Biological Chemistry Research Interest Group
- Cambridge Infectious Diseases
- Department of Chemistry
- Featured lists
- Pfizer Lecture Theatre, Department of Chemistry
- School of Physical Sciences
- Synthetic Chemistry Research Interest Group
Note: Ex-directory lists are not shown.